Company
» Management
» Board of Directors
» Scientific Advisory Board
» Investors
» Careers
Science
» Neurotrophic Factors
» Gene Delivery Technology
» Alzheimer's Disease
» Parkinson's Disease
» ALS
» Ocular Diseases
Pipeline
Clinical Trials
» About Clinical Research
» Alzheimer's
» Parkinsons's
Business Development
» Company Fact Sheet
» Business Development
Newsroom
» Press Releases
» Ceregene in the News
Contact
Home
|
Site Map
|
Contact
|
Directions
Newsroom
News Articles
09.10
Biotechnology: Crossing the barrier
02.08
Hopes High for Experimental Alzheimer's Treatment
03.07
Ceregene Bets on Better Delivery
02.07
Gene Therapy: Science in Slow Motion
01.07
Accepting the Risk in Hopes of a Cure
07.06
Central Nervous System Remains a Large Target for Novel Therapies (PDF 350k)
04.06
Alzheimer’s Trial Update
12.05
Gene therapy appears to relieve Parkinson's symptoms
11.05
Gene Therapy Is Respectable Again
09.05
Gene therapy gets a second chance
04.05
Boston Globe: Investors reconsider genetic therapies
01.05
Using gene therapy to treat Alzheimer's disease